Suchergebnisse - "Arthritis, Rheumatoid"

PubPharm (7.979)

1

Classification of rheumatoid arthritis : is it time to revise the criteria?

enthalten in: RMD open | 2024

von Steiner, G. | Verschueren, P. | Van Hoovels, L. | +2

2

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis : a post hoc analysis of a phase 3b/4 randomised safety study

enthalten in: RMD open | 2024

von Buch, M. | Bhatt, D. | Charles-Schoeman, C. | +10

3

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis

enthalten in: RMD open | 2024

von Song, Y. | Lee, J. | Jo, J. | +1

4

EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3

enthalten in: Annals of the rheumatic diseases | 2024

von Wu, G. | Cao, B. | Zhai, H. | +8

5

Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis

enthalten in: Annals of the rheumatic diseases | 2024

von Crowson, C. | Atkinson, E. | Kronzer, V. | +8

6

Shift in perspective : autoimmunity protecting against rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2024

von He, Y. | Aoun, M. | Xu, Z. | +1

7

Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test

enthalten in: RMD open | 2024

von Di Matteo, A. | Mankia, K. | Garcia-Montoya, L. | +5

8

Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis : real-world data from the BIOBADASER registry

enthalten in: Annals of the rheumatic diseases | 2024

von Hernández-Cruz, B. | Otero-Varela, L. | Freire-González, M. | +11

9

Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis : observational extension of the REDO trial

enthalten in: RMD open | 2024

von den Broeder, N. | Verhoef, L. | de Man, Y. | +7

10

Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease : a cohort study from the German RABBIT register

enthalten in: RMD open | 2024

von Rudi, T. | Zietemann, V. | Meissner, Y. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[798]